US · SERVICES-EDUCATIONAL SERVICES · SMALL CAP
NP Life Sciences Health Industry Group Inc. ACAT
5 fiscal years on record · USD · FY2023 reported
SEC FILINGS ONLY
Revenue · FY2023
$164,621
▲ 61.4% vs FY2022
EPS · FY23
$0.00
Dividend / sh · FY23
—
Payout · FY23
—
ROE · FY23
-15.2%
Net margin · FY23
-1.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 164,621.00
Revenue, FY2023 · full 5-year series below
Revenue
Net income
The company lost 2 cents on every revenue dollar this year.
Per share
USD 0.00
Diluted EPS, FY2023
EPS
The company pays no cash dividend.
Profitability
-15.2%
Return on equity, FY2023
ROE
Operating margin-0.4%
Net margin-1.8%
Return on assets-2.9%
Each USD of equity lost 15 cents this year.
Returned to shareholders
—
returned in FY2023 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+122.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2023
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 76,864.00
total assets, end of FY2023
Total assetsUSD 76,864.00
CashUSD 70,614.00
History
5 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2023
2022
2021
2020
2019
Revenue $B
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
·
·
·
·
·
Income tax $B
0.0
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
0.00
0.00
0.00
0.00
0.00
Dividend / sh $
·
·
·
·
·
Payout %
·
·
·
·
·
ROE %
−15.2
−65.6
−92.5
−77.4
−46.3
Shares out B
0.04
0.04
0.04
0.04
0.04
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
7 of 7
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed